Jounce Therapeutics is dedicated to transforming the treatment of cancer
Jounce is discovering and developing novel cancer immunotherapies designed to mobilize the immune system to seek out and attack cancerous cells and tumors. Jounce's proprietary product engine has the potential to discover novel biological insights to drive the development of game-changing immunotherapy treatments with highly durable responses, extending and improving patients' quality of life.
Jounce Therapeutics to Present at the Cowen and Company 35th Annual Health Care ConferenceRead More > >
Jounce Therapeutics Appoints Deborah Law, D. Phil., to Chief Scientific OfficerRead More > >
Jounce Therapeutics to Present at the J.P. Morgan Healthcare ConferenceRead More > >